|
3.1 Tabac
|
|
|
|
|
|
4.9 Dép., diag. & prono. - Sein
|
|
|
U.S. data show that mammograms still often begin at 40 [Reuters]
|
|
|
|
|
|
Screening
rates were lower overall in 2010 and 2012 than in previous years, the
authors report in the American Journal of Preventive Medicine, but the
proportion of women who began getting screened at age 40 increased, and
was highest after the USPSTF recommendations were issued in 2009.
|
|
|
|
|
|
|
5. Traitements
|
|
|
|
|
5.12 Immunothérapies
|
|
|
Natural Defenses [Genome Mag]
|
|
|
|
|
|
“This
is not the end of the road for this technology at all,” says Brentjens.
“We have a Model A Ford, and we want to build a Ferrari.”
|
|
|
|
|
|
|
5.2 Pharma
|
|
|
|
5.2.1 Pharma - Partenariats
|
|
|
|
|
|
|
AstraZeneca announces new cancer deals with first-quarter results [The Guardian]
|
|
|
|
|
|
The
Anglo-Swedish drugmaker also announced an alliance with US blood cancer
specialist Celgene to develop and sell AstraZeneca’s MEDI4736 – one of
its most promising new cancer drugs – across a range of blood cancers
including non-Hodgkin’s lymphoma. Another licensing deal with Innate
Pharma will combine the same drug with an antibody developed by the
French biotech firm.
|
|
|
|
|
|
|
|
5.3 Traitements - FDA, EMA,...
|
|
|
|
|
|
EMA Recommends Granting a Marketing Authorisation for Nivolumab [ESMO]
|
|
|
|
|
|
Detailed
recommendations for the use of this product will be described in the
summary of product characteristics, which will be published in the
European public assessment report and made available in all official
European Union languages after the marketing authorisation has been
granted by the European Commission.
|
|
|
|
|
|
|
5.4 Traitements - Economie
|
|
|
|
5.6 ESMO
|
|
|
|
5.9.6 AACR - prostate
|
|
|
Breast cancer drug may help men with prostate cancer [Science]
|
|
|
|
|
|
Although
genetic tests of tumors are already used to determine whether certain
drugs will work for several types of cancer, this is the first time
researchers have found such a test for prostate cancer, de Bono’s group
says. Olaparib could offer a new option for these men.
|
|
|
|
|
|
|
6. Lutte contre les cancers
|
|
|
|
|
6.10 Politiques
|
|
|
|
6.11 Patients
|
|
|
|
6.6 Publications
|
|
|
Bar graphs criticized for misrepresenting data [Nature News & Comment]
|
|
|
|
|
|
Dodgy
data analysis has come under fire in recent months, and now an article
in PLoS Biology1takes aim at another staple of statistics. It argues
that bar graphs used to describe a continuum of data are often
uninformative and misleading, and should be purged from much of the
scientific literature.
|
|
|
|
|
|
|
6.7 DMP, Big Data & applis
|
|
|
Health apps: a note of caution [Cancer Research UK]
|
|
|
|
|
|
Health
apps (applications that offer health-related services on your mobile
phone or tablet) areflooding the market. And the same goes for wearable
technology, or ‘wearables’, like the Fitbit, JawBone and most recently
the Apple Watch.
But how much can we rely on this technology? And does it actually do us
any good?
|
|
|
|
|
|